Sign In
Buy WST
$316.31
+4.14 (+1.33%)
At Close: Jun 03, 2026
Why West Pharmaceutical (WST) Might Surprise This Earnings Season
09:47am, Wednesday, 15'th Feb 2023
West Pharmaceutical (WST) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Could West Pharmaceutical Be a Value Stock?
11:16am, Thursday, 09'th Feb 2023
The health care industry has several strong tailwinds, especially among companies active in international markets. Wealth is increasing in most of the world, and that means increasing demand for healt
BDX vs. WST: Which Stock Is the Better Value Option?
12:48pm, Tuesday, 07'th Feb 2023
BDX vs. WST: Which Stock Is the Better Value Option?
West to Host Fourth-Quarter and Full-Year 2022 Conference Call and Announces Participation in Upcoming Investor Conferences
06:00am, Thursday, 02'nd Feb 2023
EXTON, Pa., Feb. 2, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will releas
My Best Dividend Aristocrats For February 2023
01:03am, Saturday, 28'th Jan 2023
NOBL fell 4.12% in December, which brings the Fund's return for the year to a loss of 6.5%. Thus far this month, through January 25th, the dividend aristocrat ETF is up 1.92% and starting the year on
Reasons to Retain West Pharmaceutical (WST) in Your Portfolio
10:32am, Wednesday, 11'th Jan 2023
West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex woes persist.
U.S. Wide-Moat Stocks On Sale: The January 2023 Heat Map
04:40pm, Thursday, 05'th Jan 2023
Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in historical comparison.
West to Participate in Upcoming Investor Conference
06:00am, Thursday, 05'th Jan 2023
EXTON, Pa. , Jan. 5, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will prese
My Best Dividend Aristocrats For January 2023
02:21pm, Monday, 26'th Dec 2022
NOBL gained 7.12% in November, which brings the Fund's return for the year to a loss of 2.14%. Thus far this month, through December 23rd, the dividend aristocrat ETF is down 3.47%, bringing its year-
West Announces First-Quarter 2023 Dividend and Participation in Upcoming Investor Conference
06:00am, Tuesday, 13'th Dec 2022
EXTON, Pa. , Dec. 13, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announces that the Company's Boar
These Are the Five Best and Worst Performing Healthcare Stocks in October 2022
08:02pm, Monday, 28'th Nov 2022
The healthcare sector has gained momentum following the COVID-19 pandemic. Several companies gained early regulatory approval for developing COVID-19 drugs and distributing vaccines.
My Best Dividend Aristocrats For December 2022
09:33am, Thursday, 24'th Nov 2022
NOBL gained 10.31% in October, which brings the Fund's return for the year to a loss of 8.96%. Thus far this month, through November 22nd, the dividend aristocrat ETF is up 6.52%, bringing its year-to
7 Dividend Stocks Set to Surge Higher in 2023
03:31pm, Monday, 21'st Nov 2022
Next year isn't very far away. In less than two months, we'll be ringing in the New Year and making resolutions.
West to Participate in Upcoming Investor Conferences
04:00pm, Friday, 04'th Nov 2022
EXTON, Pa. , Nov. 4, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will part
14 Upcoming Dividend Increases Including A Dividend King
12:20pm, Thursday, 03'rd Nov 2022
All stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List. They have an average increase of 8.8% and a median increase of 5.8%.
